Schroder Investment Management Group’s Editas Medicine EDIT Stock Holding History

Schroder Investment Management Group’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,198	Closed	-$687K	–	1324
2019 Q4	$687K	Hold	23,198	–	–	﹤0.01%	1017
2019 Q3	$522K	Buy	23,198 +1,585	+7%	+$39.3K	﹤0.01%	1039
2019 Q2	$535K	Sell	21,613 -9,222	-30%	-$220K	﹤0.01%	969
2019 Q1	$754K	Hold	30,835	–	–	﹤0.01%	949
2018 Q4	$701	Buy	30,835 +9,082	+42%	+$247K	﹤0.01%	942
2018 Q3	$692K	Hold	21,753	–	–	﹤0.01%	988
2018 Q2	$780K	Buy	+21,753	New	+$770K	﹤0.01%	981

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group's EDIT Position: Q1 2020 in Review

Schroder Investment Management Group sold out of Editas Medicine (EDIT) in Q1 2020, closing a stake of 23,198 shares — an estimated $687K sold.

Schroder Investment Management Group first reported a position in EDIT in Q2 2018 and held it in 7 quarters. The position peaked at $780K in Q2 2018. 199 funds tracked by Wall St. Rank hold EDIT as of Q1 2020.

Schroder Investment Management Group reported no remaining Editas Medicine position as of Q1 2020 after selling out during the quarter.
Schroder Investment Management Group sold 23,198 Editas Medicine shares in Q1 2020, an estimated $687K.
Schroder Investment Management Group first reported a position in Editas Medicine in Q2 2018 and held it in 7 quarters.
Schroder Investment Management Group's Editas Medicine position peaked at $780K in Q2 2018.
199 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2020.

Based on Schroder Investment Management Group's 13F filing for Q1 2020, filed 15 May 2020.